| Financial Year |
March 31 2023 |
| Monetary Funds |
1,314,052,446.96 |
| Held-for-trading Financial Assets |
10,000,000.00 |
| Notes Receivable |
3,895,000.00 |
| Accounts Receivable |
1,584,094,556.17 |
| Advances to Suppliers |
314,306,848.13 |
| Other Receivables |
36,536,557.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,204,972,213.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
480,751,236.06 |
| Other Current Assets |
159,573,599.20 |
| Total Current Assets |
5,122,480,421.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
91,157,097.80 |
| Long-term Equity Investment |
260,904,409.74 |
| Investment Properties |
-- |
| Fixed Assetes |
956,434,315.18 |
| Under-construction Projects |
8,331,642.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
245,539,905.39 |
| R&D expenses |
27,266,081.90 |
| Goodwill |
484,838,644.73 |
| Long-Term Deferred and Prepaid Expenses |
92,197,801.74 |
| Deferred Income Tax Assets |
112,235,738.65 |
| Other Non-Current Assets |
158,098,500.46 |
| Sub-Total of Non-Current Assets |
2,568,098,304.06 |
| Total Assets |
7,690,578,725.82 |
| Short-Term Loans |
1,885,681,142.37 |
| Trading Financial liabilities |
-- |
| Notes Payable |
843,182,331.28 |
| Accounts Payable |
882,511,497.63 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
101,129,999.93 |
| Taxes Payable |
33,717,072.85 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
65,263,452.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
231,926,302.82 |
| Other Current Liabilities |
28,826,405.04 |
| Sub-Total of Current Liabilities |
4,291,001,614.01 |
| Long-term Loans |
775,373,340.27 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
55,019,892.29 |
| Special Payable |
-- |
| Estimatied Liabilities |
15,727,538.80 |
| Deferred Income Tax Liabilities |
8,574,728.75 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,043,205,118.28 |
| Total Liabilities |
5,334,206,732.29 |
| Paid-In Capital(Or Share Stock) |
592,988,082.00 |
| Capital Surplus |
2,262,388,040.53 |
| Surplus Reserve |
55,005,362.11 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-636,473,563.15 |
| Minority Stockholder's Interest |
82,688,918.57 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,273,683,074.96 |
| Owner's Equity（Stockholder's Equity） |
2,356,371,993.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,690,578,725.82 |
